S32. ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS POTENTIAL THERAPEUTICS FOR SCHIZOPHRENIA?

BACKGROUND: Estrogen therapies, such as estradiol, have shown promise as therapeutics for schizophrenia; however, safety and tolerability concerns, including feminization effects in men and cancer and stroke risk in pre-menopausal women, may limit their broader use. Estradiol binds to both the estro...

Descripción completa

Detalles Bibliográficos
Autores principales: Breier, Alan, Liffick, Emily, Hummer, Tom, Vohs, Jennifer, Mehdiyoun, Nicole, Yang, Ziyi, Saykin, Andrew J, McDonald, Brenna, Francis, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Session I
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234159/
http://dx.doi.org/10.1093/schbul/sbaa031.098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234159/
http://dx.doi.org/10.1093/schbul/sbaa031.098

Ejemplares similares